Abstract Background Hyperactive coagulation might cause dangerous complications such as portal vein thrombosis and pulmonary embolism after mesenchymal stem/stromal cell (MSC) therapy. Tissue factor (TF). an initiator of the extrinsic coagulation pathway. has been suggested as a predictor of this process. https://www.knowall.blog/